The initial rule, which went into effect last year, sought to address rising concerns that some drugmakers may use payments or lavish meals to influence the prescribing of opioids.
The rule placed a $10,000 annual cap on what physicians can earn from drugmakers for speaking and promotional fees and a $15 cap on “modest meals” that are provided at educational events. The hospitality and restaurant industry said the initial proposal on meals was too restrictive.
Under the revised rule, the annual cap remains in place, but research work is exempt. Additionally, the cap for dinners was increased to $30 instead of $15, and a previous limit of four meals per year was lifted. The revised rule was filed last week.
Read the full report here.
More articles on pharmacy:
8 recent pharmaceutical lawsuits, settlements
McKesson renews distribution deal with CVS Health
Sacklers discussed selling Purdue Pharma in 2000, court documents reveal
